Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 23.40
-0.70 (-2.90%)
Nov 21, 2025, 5:00 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 429.52 million as of November 21, 2025. Its market cap has decreased by -57.68% in one year.
Market Cap
429.52M
Enterprise Value
619.53M
Revenue
130.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.40
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 429.52M, an increase of 660.17%. That is a compound annual growth rate of 15.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 429.52M | -51.75% |
| Dec 30, 2024 | 890.13M | -33.04% |
| Dec 29, 2023 | 1.33B | 16.75% |
| Dec 30, 2022 | 1.14B | 1.70% |
| Dec 30, 2021 | 1.12B | 23.98% |
| Dec 30, 2020 | 903.09M | 25.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.94B |
| NEUCA | 3.62B |
| Synektik Spólka Akcyjna | 2.22B |
| Voxel | 1.51B |
| Celon Pharma | 1.08B |
| Selvita | 805.81M |
| Centrum Medyczne ENEL-MED | 523.19M |
| Bioceltix | 447.63M |